[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90108]], camposKey:1876-0341 2025-12-01 Circulating Extracellular Vesicle miR-150¿5p as a biomarker for optimizing clinical management of sepsis and septic shock: A discovery and validation Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91344]], camposKey:2399-3642 2025-12-01 Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90109]], camposKey:1364-8535 2025-12-01 Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91346]], camposKey:0034-9356 2025-08-01 Exploring the role of flow cytometry to assess endothelial cells in human sepsis: A systematic review Explorar el rol de la citometría de flujo para la evaluación de las células endoteliales en la sepsis humana: una revisión sistemática00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=94566]], camposKey:0034-9356 2025-01-01 Explorar el rol de la citometría de flujo para la evaluación de las células endoteliales en la sepsis humana: una revisión sistemática99, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=91352]], camposKey:2399-3642 2024-12-01 Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83201]], camposKey:2045-2322 2024-12-01 Epidemiology of fungal infection in COVID 19 in Spain during 2020 and 2021: a nationwide study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=84112]], camposKey:1876-0341 2024-06-01 COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study939946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87466]], camposKey:0022-1899 2024-01-01 miRNome profiling of extracellular vesicles in severe COVID-19 patients and identification of predictors of mortality901911, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80667]], camposKey:1101-1262 2023-08-01 Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: A nationwide study675681, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76166]], camposKey:0026-4806 2023-02-01 High cobalamin levels as a five-year risk predictor for developing hematological cancer2228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76540]], camposKey:0013-9351 2023-01-01 Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75970]], camposKey:1661-6596 2022-12-01 Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65058]], camposKey:1364-8535 2022-12-01 Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76099]], camposKey:0964-6906 2022-11-10 Novel genes and sex differences in COVID-19 severity37893806, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75144]], camposKey:1664-3224 2022-09-27 Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75041]], camposKey:0025-7974 2022-08-12 PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77457]], camposKey:0025-7753 2022-07-08 Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75591]], camposKey:2077-0383 2022-06-01 Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75592]], camposKey:2296-858X 2022-04-25 ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77541]], camposKey:0025-7753 2022-01-01 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75594]], camposKey:2284-2594 2022-01-01 Fibrinogen Deficiency with Thrombotic Manifestations00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65476]], camposKey:1129-2369 2021-12-01 Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65060]], camposKey:2213-2317 2021-12-01 Lipid peroxidation as a hallmark of severity in COVID-19 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65938]], camposKey:1664-3224 2021-10-13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77464]], camposKey:0014-2565 2021-10-01 Porcelain aorta Aorta en porcelana00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65063]], camposKey:0163-4453 2021-08-01 Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression147155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83202]], camposKey:2077-0383 2021-07-02 Genetic susceptibility to acute kidney injury00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90013]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65144]], camposKey:1661-6596 2021-06-02 Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83203]], camposKey:2077-0383 2021-05-01 HGF, IL-1¿, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77466]], camposKey:2077-0383 2021-05-01 Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-01-01 Blood Biomarkers for Assessing Headaches in Healthcare Workers after Wearing Biological Personal Protective Equipment in a COVID-19 Field Hospital00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76541]], camposKey:2077-0383 2021-01-01 Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55505]], camposKey:2077-0383 2020-01-01 Gene Expression Patterns Distinguish Mortality Risk in Patients with Postsurgical Shock00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52132]], camposKey:2077-0383 2019-01-01 Nosocomial Vs. Community-Acquired Infective Endocarditis in Spain: Location, Trends, Clinical Presentation, Etiology, and Survival in the 21st Century00][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=35931]},camposKey: 259 0 Grado de satisfacción de los alumnos del Grado de Fisioterapia con las prácticas de Farmacología 8411226093Avances en educación superior e investigación 1 2021-01-01 Dykinson , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=35932]},camposKey: 260 0 Herramienta de autoevaluación para ayudar a los alumnos a afrontar el examen práctico de Farmacología 8411226093Avances en educación superior e investigación 1 2021-01-01 Dykinson ][][][][][][][][][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=756]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=756]]][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@718e1c5c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@67e8c855, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@561a9364, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6e95605a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6ff8fd28, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4ef33ae2][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463421]][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17a93, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1702b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17061, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d8b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16db0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16da0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15f3f][]